A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells

p73, a transcription factor rarely mutated in cancer, regulates a subset of p53 target genes that cause cells to respond to genotoxic stress by growth arrest and apoptosis. p73 is produced in two main forms; only TAp73 reiterates the roles of p53, while ΔNp73 can be oncogenic in character. We show that the TAp73 form produced by TP73 P1 promoter has five distinct Egr1-binding sites, each contributing to the transcriptional upregulation of TAp73 by Egr1 in several cell types. In contrast, TP73 P2 promoter transcribes ΔNp73, is not induced by Egr1, but is induced by TAp73 and p53. Induction of TAp73 by genotoxic stress requires Egr1 in mouse in vivo. Newly discovered non-consensus p53-binding sites in p73, p53 and Egr1 promoters reveal inter-regulating networks and sustained expression by feedback loops in response to stress, resulting in prolonged expression of the p53 family of genes and efficient apoptosis.

[1]  G. Melino,et al.  Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity , 1998, Journal of Experimental Medicine.

[2]  Eileen D. Adamson,et al.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.

[3]  U. Moll,et al.  ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors , 2002, The Journal of experimental medicine.

[4]  U. Moll,et al.  ΔNp73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo , 2003, Molecular and Cellular Biology.

[5]  U. Moll,et al.  p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.

[6]  Xinbin Chen,et al.  ΔNp73β Is Active in Transactivation and Growth Suppression , 2004, Molecular and Cellular Biology.

[7]  B. Pützer,et al.  Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. , 2002, Journal of Biological Chemistry.

[8]  T. Mustelin,et al.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling , 2001, Nature Cell Biology.

[9]  Jeremy R Stuart,et al.  c-Abl regulates Early Growth Response Protein (EGR1) in response to oxidative stress , 2005, Oncogene.

[10]  J. Milbrandt,et al.  Luteinizing Hormone Deficiency and Female Infertility in Mice Lacking the Transcription Factor NGFI-A (Egr-1) , 1996, Science.

[11]  Hua Lu,et al.  The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis , 2000, Molecular and Cellular Biology.

[12]  D. Mercola,et al.  Method for cloning in vivo targets of the Egr-1 transcription factor. , 2000, BioTechniques.

[13]  Mansoor M Ahmed.  Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. , 2004, Current cancer drug targets.

[14]  V. Rangnekar,et al.  Early Growth Response-1-dependent Apoptosis Is Mediated by p53* , 1997, The Journal of Biological Chemistry.

[15]  Z. Ronai,et al.  p53-Mdm2--the affair that never ends. , 2002, Carcinogenesis.

[16]  S. Sealfon,et al.  Early Single Cell Bifurcation of Pro- and Antiapoptotic States during Oxidative Stress* , 2004, Journal of Biological Chemistry.

[17]  G. Melino,et al.  p73 and p63 protein stability: the way to regulate function? , 2003, Biochemical pharmacology.

[18]  Ruo-Pan Huang,et al.  p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis , 1999, Oncogene.

[19]  Y. Pekarsky,et al.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Mercola,et al.  Egr1 Transcription Factor: Multiple Roles in Prostate Tumor Cell Growth and Survival , 2002, Tumor Biology.

[21]  Xinbin Chen,et al.  p73 is transcriptionally regulated by DNA damage, p53, and p73 , 2001, Oncogene.

[22]  D. Longo,et al.  Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression , 2004, Cancer Research.

[23]  Pierre Hainaut,et al.  p53 protein variants: structural and functional similarities with p63 and p73 isoforms , 2004, Oncogene.

[24]  M. Obinata,et al.  Possible Oncogenic Potential of ΔNp73: A Newly Identified Isoform of Human p73 , 2002 .

[25]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[26]  S. Madden,et al.  SAGE transcript profiles for p53-dependent growth regulation , 1997, Oncogene.

[27]  Dan Mercola,et al.  Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. , 2005, Cancer research.

[28]  Dan Mercola,et al.  Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Deppert,et al.  Tumor Suppressor p53 Binds with High Affinity to CTG·CAG Trinucleotide Repeats and Induces Topological Alterations in Mismatched Duplexes* , 2005, Journal of Biological Chemistry.

[30]  Xinbin Chen,et al.  DeltaNp73beta is active in transactivation and growth suppression. , 2004, Molecular and cellular biology.

[31]  D. Mercola,et al.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin , 2006, Cancer Gene Therapy.

[32]  N. Rainov,et al.  The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. , 2003, Life sciences.

[33]  A. Yang,et al.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours , 2000, Nature.

[34]  M. Obinata,et al.  Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. , 2002, Cancer research.

[35]  A. Nakagawara,et al.  Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells , 2005, Oncogene.

[36]  S. Schneider-Maunoury,et al.  Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. , 1998, Molecular endocrinology.

[37]  Tim Crook,et al.  Functional regulation of p73 and p63: development and cancer. , 2003, Trends in biochemical sciences.

[38]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[39]  M. Pignatelli,et al.  The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. , 2003, The Biochemical journal.

[40]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[41]  Kelvin K. Tsai,et al.  c-Abl stabilizes p73 by a phosphorylation-augmented interaction. , 2003, Cancer research.

[42]  E. Adamson,et al.  Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. , 2004, Molecular cell.